首页 | 本学科首页   官方微博 | 高级检索  
检索        

甲基莲心碱对乳腺癌MCF-7/Adr 细胞MDR逆转的研究
引用本文:黄程辉,曹培国.甲基莲心碱对乳腺癌MCF-7/Adr 细胞MDR逆转的研究[J].肿瘤防治研究,2007,34(5):351-354.
作者姓名:黄程辉  曹培国
作者单位:410013,长沙,中南大学湘雅三医院肿瘤科
摘    要: 目的 探讨甲基莲心碱(Neferine,Nef)对耐药人乳腺癌细胞增殖,细胞内ADM积聚浓度及mdr-1/P-gp表达的影响。方法 采用MTT法测定细胞毒作用,高效液相色谱法测定细胞内ADM积聚浓度,RT—PCR技术及蛋白质印迹技术检测mdr-1/P-gp表达。结果 10μg/ml Nef+ADM组细胞的抑制率及细胞内ADM积聚浓度比ADM组高(P〈0.01);20μg/ml Nef+ADM组细胞抑制率及细胞内ADM积聚浓度较5μg/ml异博定+ADM组及10μg/ml Nef+ADM组均高(P〈0.01)。10μg/ml Nef+ADM组MCF-7/Adr细胞mdr-1 mRNA及P-gp表达比ADM组明显下降(P〈0.01)。20μg/ml Nef+ADM组细胞mdr-1mRNA及P-gp表达较10μg/ml Nef+ADM组明显下调(P〈0.01)。结论 Nef能抑制耐药人乳腺癌细胞增殖。Nef能增加MCF-7/Adr细胞内ADM积聚浓度。Nef通过降低耐药人乳腺癌细胞mdr-1 mRNA及P-gp的表达逆转MDR。

关 键 词:甲基莲心碱  多药耐药  P-糖蛋白  MCF-7/Adr  细胞
文章编号:1000-8578(2007)05-0351-04
收稿时间:2006-5-15
修稿时间:2006-05-152006-06-14

The Study of Neferine on Multidrug Resistance Reversing of the Human Breast Cancer Cell Line MCF-7/Adr
HUANG Cheng-hui,CAO Pei-guo.The Study of Neferine on Multidrug Resistance Reversing of the Human Breast Cancer Cell Line MCF-7/Adr[J].Cancer Research on Prevention and Treatment,2007,34(5):351-354.
Authors:HUANG Cheng-hui  CAO Pei-guo
Institution:Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha 410013,China
Abstract:Objective  To investigate the effect of neferine (Nef ) on the proliferation , intracellular ADM concent ration and the expression of mdr-1/P-gp in human breast cancer cell line MCF-7/ Adr. Methods  MTT method was used to observe cell proliferation. High performance liquid chromatography was used to detect int racellular ADM concent ration. RT-PCR and Western-blotting were used to detect mdr-1/P-gp expression. Results  The inhibiting rate and int racellular ADM concent ration of 10μg/ ml Nef adding ADM group were significantly higher than those of ADM group ( P < 0. 01) . The inhibiting rate and intracellular ADM concent ration of 20μg/ ml Nef adding ADM group were significantly higher than those of 5μg/ ml verapamil adding ADM group and 10μg/ ml Nef adding ADM group ( P < 0. 01) . The mdr-1 mRNA and P-gp expression of 10μg/ml Nef adding ADM group was significantly lower than those of 60μg/ml ADM group ( P < 0. 01) . The mdr-1 mRNA and P-gp expression of 20μg/ml Nef adding ADM was significantly lower than that of 10μg/ml Nef adding ADM group group ( P < 0. 01) . Conclusion  Neferine can inhibit the proliferation of human breast cancer cell line MCF-7/Adr. Neferine can improve the int racellular ADM concent ration. Neferine can reduce mdr-1 mRNA and P-gp expression and consequently reverse MDR.
Keywords:Neferine  Multidrug resistance  P-glycoprotein  MCF 7/Adr cell line
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号